A new horizon for the steroidal alkaloid cyclovirobuxine D (huangyangning) and analogues: Anticancer activities and mechanism of action
Open Access
- 17 October 2020
- journal article
- review article
- Published by Elsevier BV in Journal of Traditional Chinese Medical Sciences
- Vol. 7 (4), 337-344
- https://doi.org/10.1016/j.jtcms.2020.10.002
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling PathwayNeuroscience, 2019
- Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in ratsBiomedicine & Pharmacotherapy, 2018
- Cytotoxicity of Triterpenoid Alkaloids from Buxus microphylla against Human Tumor Cell LinesMolecules, 2016
- Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine DDrug Design, Development and Therapy, 2016
- Influence of cyclovirobuxine D on intracellular [Ca2+] regulation and the expression of the calcium cycling proteins in rat myocytesFitoterapia, 2012
- Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarctionFitoterapia, 2011
- Triterpenoid Alkaloids from Buxus microphyllaChemistry & Biodiversity, 2010
- Cytotoxic Triterpenoid Alkaloids from Buxus microphyllaJournal of Natural Products, 2009
- Three Steroidal Alkaloids fromBuxus microphyllaJournal of Asian Natural Products Research, 1999
- Buxus alkaloids. VI. The constitution of Cyclovirobuxine-DTetrahedron Letters, 1964